Silence Therapeutics plc (NASDAQ:SLN) Q4 2024 Earnings Call Transcript February 28, 2025 Gem Hopkins: Good morning and good afternoon, everyone. Thank you for joining us today. My name is Gem Hopkins, ...
Q2 2026 Earnings Call July 30, 2026 4:30 PM EDTCompany ParticipantsZarak Khurshid - Vice President of Investor ...
Objective Complement plays a major role in SLE. Complement participation has been linked to disease activity and damage. Our objective was to estimate the association of complement behaviour with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results